Akebia Therapeutics, Inc. (AKBA)
0.5669
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.5635
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price to Book Value : 6.157 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.157 |
| October 22, 2026 | 6.106 |
| October 21, 2026 | 6.357 |
| October 20, 2026 | 6.713 |
| October 19, 2026 | 7.387 |
| October 16, 2026 | 7.277 |
| October 15, 2026 | 7.554 |
| October 14, 2026 | 7.625 |
| October 13, 2026 | 8.363 |
| October 12, 2026 | 8.583 |
| October 09, 2026 | 8.701 |
| October 08, 2026 | 8.850 |
| October 07, 2026 | 9.486 |
| October 06, 2026 | 9.542 |
| October 05, 2026 | 9.889 |
| October 02, 2026 | 9.395 |
| October 01, 2026 | 9.460 |
| September 30, 2026 | 9.992 |
| September 29, 2026 | 9.624 |
| September 28, 2026 | 9.700 |
| September 25, 2026 | 9.734 |
| September 24, 2026 | 9.982 |
| September 23, 2026 | 10.13 |
| September 22, 2026 | 10.64 |
| September 21, 2026 | 10.19 |
| Date | Value |
|---|---|
| September 18, 2026 | 9.946 |
| September 17, 2026 | 9.726 |
| September 16, 2026 | 9.968 |
| September 15, 2026 | 9.808 |
| September 14, 2026 | 10.46 |
| September 11, 2026 | 10.34 |
| September 10, 2026 | 10.28 |
| September 09, 2026 | 10.36 |
| September 08, 2026 | 11.19 |
| September 04, 2026 | 10.59 |
| September 03, 2026 | 10.68 |
| September 02, 2026 | 10.65 |
| September 01, 2026 | 10.26 |
| August 31, 2026 | 9.979 |
| August 28, 2026 | 9.543 |
| August 27, 2026 | 10.21 |
| August 26, 2026 | 9.846 |
| August 25, 2026 | 10.41 |
| August 24, 2026 | 9.782 |
| August 21, 2026 | 9.847 |
| August 20, 2026 | 9.986 |
| August 19, 2026 | 9.617 |
| August 18, 2026 | 9.252 |
| August 17, 2026 | 9.341 |
| August 14, 2026 | 9.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Emergent BioSolutions, Inc. | 0.9361 |
| Exelixis, Inc. | 8.711 |
| ADMA Biologics, Inc. | 5.896 |
| Arcutis Biotherapeutics, Inc. | 17.76 |
| Relay Therapeutics, Inc. | 4.464 |
Price to Book Value Related Metrics
| PS Ratio | 0.6964 |
| Price to Free Cash Flow | 3.789 |
| Price | 0.5669 |
| Earnings Yield | -19.58% |
| Market Cap | 154.05M |